The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Biomarker analysis for UPCI 14-118: Phase II study of pembrolizumab in combination with azacitidine in patients with refractory metastatic colorectal cancer.
 
Chaoyuan Kuang
(OPTIONAL) Uncompensated Relationships - Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Celgene; Celgene; Celgene; Celgene; Incyte; Incyte; Incyte; Incyte; Lilly; Lilly; Lilly; Lilly; Pharmacyclics; Pharmacyclics; Pharmacyclics; Pharmacyclics
 
Yongseok Park
No Relationships to Disclose
 
Nathan Bahary
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Exelixis; Exelixis; Exelixis; Exelixis; Thermo Fisher Scientific; Thermo Fisher Scientific; Thermo Fisher Scientific; Thermo Fisher Scientific
 
Weijing Sun
Honoraria - Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - Bayer; Bayer; Bayer; Bayer
Research Funding - Bayer; Bayer; Bayer; Bayer; Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst)
 
James Ohr
No Relationships to Disclose
 
John C. Rhee
No Relationships to Disclose
 
Stanley M. Marks
Employment - IntegraConnect (I); IntegraConnect (I); IntegraConnect (I); IntegraConnect (I)
Consulting or Advisory Role - Dendreon; Dendreon; Dendreon; Dendreon
 
H. Scott Beasley
No Relationships to Disclose
 
Yongli Shuai
No Relationships to Disclose
 
Yan Lin
No Relationships to Disclose
 
Reetesh K. Pai
No Relationships to Disclose
 
Anuradha Krishnamurthy
No Relationships to Disclose
 
Hassane M. Zarour
Research Funding - Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst); Merck Sharp & Dohme (Inst); Merck Sharp & Dohme (Inst); Merck Sharp & Dohme (Inst); Tesaro (Inst); Tesaro (Inst); Tesaro (Inst); Tesaro (Inst)
 
James Herman
No Relationships to Disclose
 
Edward Chu
Consulting or Advisory Role - Proteus Digital Health; Proteus Digital Health; Proteus Digital Health; Proteus Digital Health
 
James J. Lee
Consulting or Advisory Role - Abbvie; Abbvie; Abbvie; Abbvie; Incyte; Incyte; Incyte; Incyte; Loxo; Loxo; Loxo; Loxo
Research Funding - Merck; Merck; Merck; Merck